<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.4'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//www.bioredbrasil.com.br/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://www.bioredbrasil.com.br/rio-de-janeiro-recebe-encontros-nacionais-sobre-acesso-a-saude-e-judicializacao/</loc>
  <lastmod>2026-11-04T14:20:14Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Rio de Janeiro recebe encontros nacionais sobre acesso à saúde e judicialização</news:title>
   <news:publication_date>2026-11-04T14:19:21Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/conselho-federal-de-medicina-tera-mais-poder-na-prova-que-decidira-exercicio-da-profissao/</loc>
  <lastmod>2026-10-30T13:56:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Conselho Federal de Medicina terá mais poder na prova que decidirá exercício da profissão</news:title>
   <news:publication_date>2026-11-04T13:30:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/seu-medicamento-pode-estar-no-lugar-errado-dentro-de-casa/</loc>
  <lastmod>2026-11-03T22:14:57Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Seu medicamento pode estar no lugar errado dentro de casa</news:title>
   <news:publication_date>2026-11-04T12:30:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/novos-tratamentos-no-sus-veja-o-que-a-conitec-vai-avaliar-em-novembro/</loc>
  <lastmod>2026-11-04T02:09:06Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Novos tratamentos no SUS: veja o que a Conitec vai avaliar em novembro</news:title>
   <news:publication_date>2026-11-04T10:30:29Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/medicamento-que-revolucionou-o-tratamento-da-hipertensao-pulmonar-pode-entrar-no-sus-2/</loc>
  <lastmod>2026-11-04T01:55:03Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Medicamento que revolucionou o tratamento da hipertensão pulmonar pode entrar no SUS </news:title>
   <news:publication_date>2026-11-03T21:30:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/lupus-voce-sabe-qual-e-a-sua-meta-de-tratamento/</loc>
  <lastmod>2026-11-04T01:54:52Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Lúpus: você sabe qual é a sua meta de tratamento?</news:title>
   <news:publication_date>2026-11-03T19:20:50Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/coparticipacao-em-planos-de-saude-avanca-sem-limite-definido-e-ans-tenta-rever-regra-de-1998/</loc>
  <lastmod>2026-10-29T17:23:43Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Coparticipação em planos de saúde avança sem limite definido, e ANS tenta rever regra de 1998</news:title>
   <news:publication_date>2026-11-03T13:30:24Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/brasil-tem-custo-de-pesquisa-clinica-ate-69-menor-que-nos-eua-e-atrai-investimentos-de-multinacionais/</loc>
  <lastmod>2026-10-29T14:56:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Brasil tem custo de pesquisa clínica até 69% menor que nos EUA e atrai investimentos de multinacionais</news:title>
   <news:publication_date>2026-11-02T17:30:04Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/eloratzp-novo-medicamento-chega-a-23-de-perda-de-peso-em-pessoas-com-diabetes/</loc>
  <lastmod>2026-10-29T14:21:46Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>EloraTZP: novo medicamento chega a 23% de perda de peso em pessoas com diabetes</news:title>
   <news:publication_date>2026-11-02T13:30:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
